PLEKHG1 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 3.975400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
3.459400E-01
Normal-vs-Stage2
4.105600E-01
Normal-vs-Stage3
3.216600E-01
Normal-vs-Stage4
4.002400E-01
Stage1-vs-Stage2
3.825800E-01
Stage1-vs-Stage3
7.163200E-01
Stage1-vs-Stage4
1.400580E-01
Stage2-vs-Stage3
3.157400E-01
Stage2-vs-Stage4
4.315400E-01
Stage3-vs-Stage4
1.069410E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
3.930200E-01
Normal-vs-AfricanAmerican
4.563800E-01
Normal-vs-Asian
3.657400E-01
Caucasian-vs-AfricanAmerican
5.567000E-01
Caucasian-vs-Asian
5.938200E-01
AfricanAmerican-vs-Asian
4.216600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
3.861400E-01
Normal-vs-Female
4.140400E-01
Male-vs-Female
3.722200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
3.088000E-01
Normal-vs-Age(41-60Yrs)
4.500800E-01
Normal-vs-Age(61-80Yrs)
3.820400E-01
Normal-vs-Age(81-100Yrs)
3.418000E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
4.287200E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
7.996200E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
8.601600E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
6.312400E-02
Age(41-60Yrs)-vs-Age(81-100Yrs)
7.592400E-02
Age(61-80Yrs)-vs-Age(81-100Yrs)
4.566600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
3.902000E-01
Normal-vs-Daily Drinker
3.197200E-01
Normal-vs-Weekly Drinker
3.787200E-01
Normal-vs-Occasional Drinker
3.681800E-01
Normal-vs-Social Drinker
4.819200E-01
Non Drinker-vs-Daily Drinker
1.723350E-01
Non Drinker-vs-Weekly Drinker
8.555400E-01
Non Drinker-vs-Occasional Drinker
7.132800E-01
Non Drinker-vs-Social Drinker
3.056200E-01
Daily Drinker-vs-Weekly Drinker
2.599000E-01
Daily Drinker-vs-Occasional Drinker
3.672000E-01
Daily Drinker-vs-Social Drinker
3.460200E-02
Weekly Drinker-vs-Occasional Drinker
8.653000E-01
Weekly Drinker-vs-Social Drinker
2.873600E-01
Occasional Drinker-vs-Social Drinker
2.248600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
2.789600E-01
Normal-vs-Grade 2
2.632200E-02
Normal-vs-Grade 3
2.465900E-02
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
7.912500E-02
Grade 1-vs-Grade 3
2.899400E-01
Grade 1-vs-Grade 4
2.789600E-01
Grade 2-vs-Grade 3
2.605200E-01
Grade 2-vs-Grade 4
2.632200E-02
Grade 3-vs-Grade 4
2.465900E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
4.028800E-01
Normal-vs-NonDiabetic
3.724600E-01
Diabetic-vs-NonDiabetic
4.358200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
3.760600E-01
Normal-vs-NoPancreatitis
3.837200E-01
Pancreatitis-vs-NoPancreatitis
8.143400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
3.727800E-01
Normal-vs-N1
4.152400E-01
N0-vs-N1
2.011200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
3.315600E-01
Normal-vs-TP53-NonMutant
3.747800E-01
TP53-Mutant-vs-TP53-NonMutant
3.136200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
